Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M51,770Revenue $M20,272Net Margin (%)13.6Altman Z-Score2.0
Enterprise Value $M59,432EPS $3.6Operating Margin %18.4Piotroski F-Score8
P/E(ttm)19.0Beneish M-Score-2.8Pre-tax Margin (%)16.3Higher ROA y-yY
Price/Book2.310-y EBITDA Growth Rate %14.6Quick Ratio0.9Cash flow > EarningsY
Price/Sales2.65-y EBITDA Growth Rate %4.8Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow15.9y-y EBITDA Growth Rate %104ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %2.2PEG4.0ROE % (ttm)11.9Less Shares Outstanding y-yN
Payout Ratio %43.0Shares Outstanding M848ROIC % (ttm)9.6Gross Margin Increase y-yY

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TEVAGeorge Soros 2015-03-31 Sold Out -3.1%$54.93 - $62.65
($58.14)
$ 61.055%Sold Out0
TEVAVanguard Health Care Fund 2015-03-31 Reduce-0.41%$54.93 - $62.65
($58.14)
$ 61.055%Reduce 61.47%1,896,960
TEVAFirst Eagle Investment 2015-03-31 Add0.26%$54.93 - $62.65
($58.14)
$ 61.055%Add 71.77%4,205,481
TEVANWQ Managers 2015-03-31 Reduce-0.24%$54.93 - $62.65
($58.14)
$ 61.055%Reduce 8.53%3,669,079
TEVADavid Dreman 2015-03-31 Reduce-0.09%$54.93 - $62.65
($58.14)
$ 61.055%Reduce 16.44%100,133
TEVAMichael Price 2015-03-31 Reduce-0.05%$54.93 - $62.65
($58.14)
$ 61.055%Reduce 1.61%440,300
TEVAJames Barrow 2015-03-31 Reduce-0.05%$54.93 - $62.65
($58.14)
$ 61.055%Reduce 5.85%10,189,904
TEVARonald Muhlenkamp 2015-03-31 Add$54.93 - $62.65
($58.14)
$ 61.055%Add 0.18%176,710
TEVAJohn Keeley 2015-03-31 Reduce$54.93 - $62.65
($58.14)
$ 61.055%Reduce 2.95%36,835
TEVATom Gayner 2014-12-31 Sold Out -0.67%$49.86 - $58.72
($55.72)
$ 61.0510%Sold Out0
TEVAGeorge Soros 2014-12-31 Reduce-0.55%$49.86 - $58.72
($55.77)
$ 61.059%Reduce 22.01%4,859,966
TEVANWQ Managers 2014-12-31 Reduce-0.39%$49.86 - $58.72
($55.72)
$ 61.0510%Reduce 14.62%4,011,187
TEVAMichael Price 2014-12-31 Reduce-0.36%$49.86 - $58.72
($55.77)
$ 61.059%Reduce 10.50%447,500
TEVADavid Dreman 2014-12-31 Reduce-0.16%$49.86 - $58.72
($55.77)
$ 61.059%Reduce 23.89%119,838
TEVAFirst Eagle Investment 2014-12-31 Add0.14%$49.86 - $58.72
($55.72)
$ 61.0510%Add 72.35%2,448,310
TEVAVanguard Health Care Fund 2014-12-31 Reduce-0.06%$49.86 - $58.72
($55.76)
$ 61.059%Reduce 8.19%4,923,200
TEVAJames Barrow 2014-12-31 Add0.03%$49.86 - $58.72
($55.76)
$ 61.059%Add 4.37%10,823,115
TEVAJohn Keeley 2014-12-31 Reduce-0.01%$49.86 - $58.72
($55.72)
$ 61.0510%Reduce 20.45%37,955
TEVARonald Muhlenkamp 2014-12-31 Reduce$49.86 - $58.72
($55.76)
$ 61.059%Reduce 0.27%176,385
TEVACharles Brandes 2014-12-31 Buy $49.86 - $58.72
($55.72)
$ 61.0510%New holding3,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TEVA is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


TEVA: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about TEVA :

    Quarterly/Annual Reports about TEVA:

      News about TEVA:

      Articles On GuruFocus.com
      Teva Puts Forth Its Best Bid To Acquire Mylan Apr 25 2015 
      Teva Eyeing Mylan For $40 Billion Apr 23 2015 
      M&A’s Driving The Stock Indexes Ahead Apr 06 2015 
      Analysts Weigh in on Auspex Pharmaceuticals Following Teva Acquisition Mar 31 2015 
      Vanguard Health Care Fund Comments on Teva Pharmaceutical Industries Ltd Mar 27 2015 
      Vanguard Health Care Fund 2014 Annual Report Mar 27 2015 
      Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
      Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals Feb 04 2015 
      Weekly 52-Week Highs Highlight: ITW, ESRX, TEVA, CHD, STI Dec 08 2014 
      Zoetis in a Growing Global Animal Health Industry Dec 03 2014 

      More From Other Websites
      Dealpolitik: Why Lawyers Need to Care About the Mylan-Kirkland Battle May 22 2015
      How Much is Actavis Worth? A Lot More Than It is Now May 22 2015
      Law Firm Advising Teva Dismisses Mylan Objections May 21 2015
      Energy Stocks Dominating Billionaire Izzy Englander’s Top Holdings: NextEra Energy Inc (NEE),... May 21 2015
      Endo buying Par for $8B in push for generics, higher profit May 18 2015
      George Soros' Latest Moves: Energy, Tech, ETFs, Pharma & More May 18 2015
      Billionaire Soros Buys Homebuilders, Energy Shares, Exits Teva May 15 2015
      IPO Stock Watch: Alder Soars On Migraine Drug Results May 15 2015
      Teva Presents Encouraging Data from Chronic Migraine Study - Analyst Blog May 15 2015
      Teva to Present New Respiratory Data at 2015 Annual International Meeting of the American Thoracic... May 15 2015
      Teva to Present New Respiratory Data at 2015 Annual International Meeting of the American Thoracic... May 15 2015
      Teva Presents Further Data from Phase IIb with TEV-48125 in Chronic Migraine at the International... May 14 2015
      Teva Presents Further Data from Phase IIb with TEV-48125 in Chronic Migraine at the International... May 14 2015
      An Attractive M&A Play In The Busy Biotech Space May 13 2015
      Dealpolitik: 2015 May Be an Expensive Tax Year for Some Mylan Shareholders May 13 2015
      Perrigo (PRGO) Buys Patheon's Mexican Business for $34M - Analyst Blog May 13 2015
      Tamir Capital soars after court ruling against Teva, 28.04.15 May 13 2015
      Eagle Pharmaceuticals, Inc. Reports First Quarter 2015 Results May 12 2015
      Mylan chairman said to consider Perrigo sweeteners to make deal -Bloomberg May 11 2015
      Mylan Chairman Considers Perrigo Sweeteners to Make Deal May 11 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK